Skip to main content

Table 5 Comparison of the dosimetry outcomes

From: A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy

   

Kidneys

Red marrow

Tumour lesions

Mono-exponential

Absolute difference (Gy/GBq)

Bias

0.026 ± 0.12

0.047 ± 0.019

−0.37 ± 0.86

95% LOA

−0.37 − 0.42

0.01 − 0.08

−2.05 − 1.31

Relative difference (%)

Bias

−0.53 ± 29.03

116 ± 38.5

−8.36 ± 19.19

95% LOA

−57.4 − 56.4

41.0 − 192

−46.0 − 26.3

Spearman correlation

0.903

−0.701

0.963

ICC - agreement

0.708

Negative

0.804

Bi-exponential

Absolute difference (Gy/GBq)

Bias

−0.042 ± 0.16

0.088 ± 0.015

0.39 ± 0.92

95% LOA

−0.348 − 0.265

0.057 − 0.118

−1.41 − 2.19

Relative difference (%)

Bias

−5.63 ± 32.07

169 ± 12.8

−9.52 ± 26.66

95% LOA

−68.5 − 57.2

144 − 194

−42.7 − 61.8

Spearman correlation

0.491

−0.418

0.907

ICC - agreement

0.537

Negative

0.921

  1. LOA limits of agreement, ICC intraclass correlation coefficient